The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of...

Go to the page now

About Genbiotech

Our primary fields of interest are rheumatology, dermatology and gynecology. We have many ongoing projects in these fields and have already marketed one product in gynecology called Endocell...

Go to the page now

Our Products

We are looking for investors on our various ongoing projects in the field of rheumatology, dermatology and gynecology. We are also open for collaborations on projects from other therapeutic areas...

Go to the page now

Investors

The main sponsors of Genbiotech are the Laboratoires Genévrier. Genbiotech has recently received a grant from Oséo to finance its research and development on the dermatology project (GBT013) on...

Go to the page now

Sponsorships

GENBIOTECH is recruiting

Recent news

view all 24/02/17

GENBIOTECH is recruiting

GENBIOTECH is actively recruiting

Read more
A new controlled atmosphere structure

Recent news

view all 31/01/17

A new controlled atmosphere structure

Genbiotech is strengthening its investment on its unique encapsulation device

Read more
Jacobs Journal of Clinical Trials

Recent news

view all 07/11/16

Jacobs Journal of Clinical Trials

An article from GENBIOTECH's team has been published in Jacobs Journal of Clinical Trial

Read more
FETE DE LA SCIENCE 2016

Recent news

view all 28/09/16

FETE DE LA SCIENCE 2016

Genbiotech will be present on the "Village des sciences et de l'innovation" in Antibes Juan-Les-Pins

Read more
Journal of wound care

Recent news

view all 18/07/16

Journal of wound care

Journal of wound care 2016 Jul 2;25(7):406-13

Read more
"Programme d'Investissement d'Avenir"

Recent news

view all 15/03/16

"Programme d'Investissement d'Avenir"

GENBIOTECH announces the participation...

Read more

Recent news

view all 01/03/16

Genbiotech and TxCell sign a partnership agreement on the use of its technical platform

Genbiotech and TxCell announced the signing of a two years partnership agreement for the use of a part of its class B facilities.

Read more